Learn More
Tone thresholds and speech-reception thresholds were measured in 200 individuals (400 ears) with noise-induced hearing loss. The speech-reception thresholds were measured in a quiet condition and in noise with a speech spectrum at levels of 35, 50, 65, and 80 dBA. The tone audiograms could be described by three principal components: hearing loss in the(More)
Both meaningful (sense) and meaningless (nonsense) syllables of the consonant-vowel-consonant type (CVC syllables) and short sentences consisting of 8 or 9 syllables were presented in quiet and in noise to 20 young subjects with normal hearing and to three groups of 20 subjects each with presbycusis, with Menière's disease and with noise-induced hearing(More)
Adjusting the speech processor of a cochlear implant, per electrode, to the individual's response is a laborious task that may interfere with a user-friendly start of implant-mediated hearing, particularly in children. This research concerns the possibility of processor adjustment based on a profile derived from measurements of the electrically evoked(More)
Cisplatin-induced ototoxicity is correlated with functional and morphological changes in the organ of Corti, the stria vascularis and the spiral ganglion. However, the cochlear sites of cisplatin uptake and accumulation have not been properly identified. Therefore, we have developed an immunohistochemical method to, indirectly, detect cisplatin in semithin(More)
Cisplatin is frequently used in the treatment of various forms of malignancies. Its therapeutic efficacy, however, is limited by the occurrence of sensorineural hearing loss. Little is known about the course of hearing loss over longer time intervals after cessation of cisplatin administration. Infrequently, recovery of hearing has been described in animals(More)
Cisplatin is one of the most potent antineoplastic drugs presently known, but its therapeutic efficacy is seriously limited by several side effects such as ototoxicity. Several compounds that are known for their nephroprotective effects also seem to reduce the incidence and severity of cisplatin-induced ototoxicity. Hamers et al. (1994) and De Groot et al.(More)
We investigated the key tissues that are implicated in cisplatin ototoxicity within the time window during which degeneration starts. Guinea pigs were treated with cisplatin at a dose of 2 mg/kg/day for either 4, 6, or 8 consecutive days. Histological changes in the organ of Corti, the stria vascularis and the spiral ganglion were quantified at the light(More)
Firecrackers produce sound impulses reaching peak levels measured at the ear sometimes in excess of 160 dB when fired at 2 m distance. These sound levels are potentially hazardous to the ear. Current damage risk criteria for impulse sounds show that for 10 impulses the peak levels should not exceed 149 dB(lin,peak) at the ear. The A-weighted, impulse(More)
Low-frequency sound was used to modulate responses to short single-frequency tone bursts at the guinea pig round window. Summating potentials (SP) increase (reach higher positive values) during the negative half-cycle of the low-frequency cochlear microphonic (LFCM) and decrease during the positive half-cycle of the LFCM. The compound action potential (AP)(More)
It has previously been demonstrated that ototoxicity induced by systemic administration of cisplatin is reduced by concomitant systemic administration of alpha-melanocyte stimulating hormone (alpha-MSH). In this study we investigated the effects of cochlear, perilymphatic application of alpha-MSH during intraperitoneal administration of cisplatin. Guinea(More)